Microbiological and molecular assessment of bacteriophage ISP for the control of Staphylococcus aureus

Medicine and Dentistry

• Staphylococcus Aureus 100%
• Bacteriophage 100%
• Infection 66%
• Phage Therapy 66%
• Methicillin Resistant Staphylococcus Aureus 66%
• Adverse Event 33%
• Finger Dermatoglyphics 33%
• Proteomics 33%
• Sequence Homology 33%
• Antibiotic Resistance 33%
• Electrospray Mass Spectrometry 33%
• Health Care 33%
• Microarray Analysis 33%
• Host Range 33%
• Bacterial Mutation 33%
• Tandem Mass Spectrometry 33%
• Electrospray Ionization 33%
• DNA Microarray 33%
• Gene Product 33%
• Structural Protein 33%

Immunology and Microbiology

• Bacteriophage 100%
• Staphylococcus Aureus 100%
• Methicillin-Resistant Staphylococcus Aureus 40%
• Bacterial Population 20%
• Antimicrobial Resistance 20%
• Infectious Disease 20%
• Electrospray Ionization 20%
• Host Range 20%
• Finger Dermatoglyphics 20%
• Sequence Homology 20%
• Tandem Mass Spectrometry 20%
• Leporidae 20%
• Bacterial Mutation 20%
• Electrospray Mass Spectrometry 20%
• DNA Microarray 20%
• Gene Product 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Staphylococcus Aureus 100%
• Bacteriophage 100%
• Infection 40%
• Methicillin-Resistant Staphylococcus Aureus 40%
• Leporidae 20%
• Adverse Event 20%
• Structural Protein 20%
• Electrospray Ionization 20%
• Antibiotic Resistance 20%